Medico Remedies Current Share Price | Medico Remedies Stock Screener
MEDICO
Pharmaceuticals
Medico Remedies Current Stock Price Today
Live Share Price NSE
₹34.89
▼
-1.45 (-3.99%)
Live Share Price BSE
₹35.01
▼
-1.18 (-3.26%)
As of September 18, 2026, the live Medico Remedies share price (NSE: MEDICO) is ₹34.89 on NSE and ₹35.01 on BSE, down 3.99% from the previous close, with shares trading between ₹34.71 and ₹36.57 in today's trading session, and a 52-week range of ₹32.76–₹54.24.
Browse Medico Remedies annual reports to support your investment research.
Use the Medico Remedies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Medico Remedies Market Cap
₹296.09 Cr.
MEDICO P/E Ratio (TTM)
21.69
Medico Remedies P/B Ratio
3.96
EPS (TTM)
₹1.58
Dividend Yield
-
Debt to Equity
0.24
MEDICO 52 Week High
₹54.24
Medico Remedies 52 Week Low
₹32.76
Operating Margin
8.00%
Profit Margin
5.74%
MEDICO Revenue (TTM)
₹244.00
EBITDA
₹24.00
Net Income
₹14.00
Total Assets
₹153.00
Total Equity
₹76.00
Medico Remedies Current Share Price Chart
Track the current Medico Remedies share price and stock price with an interactive chart. Analyse MEDICO price trends, trading volume, historical performance, and volatility across different timeframes — the complete Medico Remedies stock quote in one place.
Medico Remedies Company Profile - Fundamental Screener
Screen Medico Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MEDICO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE630Y01024
Medico Remedies Balance Sheet Screener
Screen MEDICO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 153 | 120 | 96 | 87 | 77 | 76 | 75 | 76 | 59 | 48 |
| Current Assets | 129 | 97 | 74 | 65 | 58 | 59 | 57 | 59 | 46 | 38 |
| Fixed Assets | 20 | 21 | 22 | 22 | 18 | 15 | 13 | 12 | 7 | 7 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 1 | 2 | 3 | 5 | 5 | 3 | 3 | 11 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 76 | 63 | 52 | 44 | 37 | 33 | 30 | 28 | 27 | 16 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 4 | 4 | 4 | 4 | 3 |
| Reserves & Surplus | 59 | 46 | 36 | 27 | 20 | 28 | 26 | 24 | 23 | 13 |
Medico Remedies Income Statement Screener - Profit & Revenue Analysis
Screen Medico Remedies income statement and profit fundamentals.
Analyze MEDICO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Medico Remedies share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 244 | 212 | 154 | 147 | 144 | 123 | 123 | 91 | 100 | 62 | 55 | 67 | 51 |
| Expenses | 220 | 189 | 136 | 132 | 131 | 114 | 117 | 86 | 95 | 58 | 50 | 63 | 48 |
| EBITDA | 24 | 23 | 18 | 15 | 14 | 9 | 6 | 5 | 5 | 4 | 4 | 4 | 3 |
| Operating Profit % | 8.00% | 8.00% | 10.00% | 9.00% | 7.00% | 6.00% | 4.00% | 3.00% | 3.00% | 6.00% | 7.00% | 5.00% | 6.00% |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| Interest | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Profit Before Tax | 19 | 18 | 14 | 11 | 10 | 7 | 4 | 2 | 2 | 2 | 2 | 2 | 1 |
| Tax | 5 | 5 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 0 |
| Net Profit | 14 | 13 | 10 | 8 | 7 | 5 | 3 | 2 | 2 | 1 | 2 | 1 | 1 |
| EPS | 1.70 | 1.58 | 1.22 | 1.00 | 0.87 | 0.58 | 1.56 | 3.93 | 3.78 | 3.65 | 5.09 | 3.53 | 5.91 |
Medico Remedies Cash Flow Screener - Liquidity Fundamentals
Screen MEDICO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 6 | 5 | 2 | 8 | 6 | -11 | 1 | 5 | 5 | -3 |
| Investing Activities | -5 | -4 | -3 | -7 | -2 | -17 | -3 | -4 | -5 | -3 |
| Financing Activities | -1 | -1 | -1 | -2 | -6 | 18 | 3 | -1 | -1 | 6 |
| Net Cash Flow | 1 | 1 | -1 | 0 | -2 | -10 | 1 | 0 | -1 | 0 |
Medico Remedies Shareholding Pattern Screener
See Medico Remedies shareholding pattern with promoter, FII, and DII holdings.
Check Medico Remedies promoter holding and ownership changes for MEDICO on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 61.38% | 61.38% | 63.79% | 62.59% | 61.38% | 61.38% | 73.34% | 73.34% |
| FII Holding | 0.03% | 0.08% | 0.12% | 0.07% | 0.30% | 0.49% | 0.29% | 0.23% |
| DII Holding | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 0.00% | 0.74% | 0.97% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.56% | 23.68% | 22.13% | 22.79% | 23.11% | 22.72% | 14.39% | 17.49% |
| Other Holding | 15.03% | 14.86% | 13.94% | 14.53% | 15.19% | 15.41% | 11.24% | 7.98% |
| Shareholder Count | 16,189 | 15,863 | 15,424 | 16,474 | 18,503 | 16,562 | 10,685 | 12,902 |
Medico Remedies Share Dividend Screener - Share Yield Analysis
Check Medico Remedies dividend history with payout and yield data.
View Medico Remedies dividend details including ex-dates and amounts for MEDICO stock.
Medico Remedies Stock Index Membership
See which indices include Medico Remedies stock.
Check MEDICO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Medico Remedies Market Events Screener - Corporate Actions
Get Medico Remedies corporate actions including splits, bonuses, and buybacks.
Check Medico Remedies stock events that may affect MEDICO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-22 | 2026-09-22 | Annual General Meeting | NA | -13.31% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 1.82% |
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | 4.98% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 1.62% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 7.58% |
| 2025-09-08 | 2025-09-08 | Annual General Meeting | NA | -1.85% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -4.01% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | -6.35% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 1.86% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 4.05% |
| 2024-09-05 | 2024-09-05 | Annual General Meeting | NA | 20.82% |
| 2023-03-16 | 2023-03-16 | Split | 2:10 | 16.61% |
| 2021-11-16 | 2021-11-17 | Bonus | 3:1 | -7.80% |
Medico Remedies Competitors Screener - Peer Comparison
Screen MEDICO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 440,278 | 36.48 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 244,178 | 84.64 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 184,478 | 87.77 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 110,585 | 24.32 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,140 | 32.86 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 104,025 | 97.64 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,570 | 30.44 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 95,513 | 25.98 | 34,145 | 5.56% | 3,503 | 53.00 |
| Lupin | 94,336 | 17.27 | 29,039 | 26.75% | 5,356 | 24.64 |
| Mankind Pharma | 94,184 | 45.49 | 14,636 | 14.85% | 1,938 | 37.66 |
Medico Remedies Company Announcements - News Screener
Screen MEDICO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-29 | Reg. 34 (1) Annual Report. | - |
| 2026-08-29 | Intimation Of Book Closure Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-29 | Submission Of Annual Report For The Financial Year 2025-26 Along With The Notice Of The 32Nd Annual General Meeting | - |
| 2026-08-17 | Clarification On Price Movement | - |
| 2026-08-13 | Financial Results For The Quarter Ended On 30Th June 2026 | - |
| 2026-08-10 | Board Meeting Intimation for Intimation Of Board Meeting. | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-08-03 | Clarification sought from Medico Remedies Ltd | - |
| 2026-06-30 | Closure of Trading Window | - |
| 2026-06-29 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-06-03 | Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-21 | Audited Standalone Financial Results Of The Company For The Quarter Ended 31St March 2026 And Audited Financial Statements For The Year Ended On 31St March 2026 Along With The AuditorS Report Thereon | - |
| 2026-05-21 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-05-21 | Board Meeting Outcome for Outcome Of Board Meeting Held Today | - |
| 2026-05-15 | Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday 21St May 2026 | - |
| 2026-04-16 | Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations) | - |
| 2026-02-24 | Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations) | - |
| 2026-02-24 | Clarification With Regards To Additional Details Sought In Respect Of Outcome Of Board Meeting Held On 18Th February 2026 Submitted To Exchange On 18Th February 2026 | - |
| 2026-02-18 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-02-12 | Financial Results For The Quarter Ended 31St December 2025 | - |